Table 1.

Baseline demographic, clinical and laboratory data for patients in the SVR, BT/R, and NR groups.

Variable	SVR Group (n=140)		BT/R Group (n=77)		NR Group (n=309)		p-value*
	N or mean	% or SD	N or mean	% or SD	N or mean	% or SD
Age (years)	48.6	6.1	48.6	5.7	49.6	7.6	0.23
Gender
Male	107	76.4%	57	74.0%	215	69.6%	0.30
Female	33	23.6%	20	26.0%	94	30.4%
Race/ethnicity
White	112	80.0%	62	80.5%	209	67.6%	0.001
Black	8	5.7%	3	3.9%	61	19.7%
Hispanic	15	10.7%	10	13.0%	28	9.1%
Others	5	3.6%	2	2.6%	11	3.6%
Stratum
Fibrosis	111	79.3%	53	68.8%	177	57.3%	<0.0001
Cirrhosis	29	20.7%	24	31.2%	132	42.7%
Ishak fibrosis score	3.6	1.2	3.9	1.2	4.2	1.3	<0.0001
Steatosis score	1.2	0.88	1.1	0.96	1.4	0.84	0.02
Genotype 1
Yes	101	72.1%	65	85.5%	291	94.5%	<0.0001
No	39	27.9%	11	14.5%	17	5.5%
Genotype 3
Yes	14	10.0%	5	6.6%	8	2.6%	0.004
No	126	90.0%	71	93.4%	300	97.4%
Body Mass Index (BMI)	29.3	5.5	29.4	5.3	30.2	5.7	0.16
WBC ×1000/mm3	6.17	2.1	5.98	1.98	5.62	1.73	0.01
Hemoglobin, g/dL	15.5	1.35	15.1	1.43	14.9	1.38	0.001
Platelet count ×1000/mm3	180.2	59.2	180.7	55.8	164.2	70.5	0.02
Creatinine, mg/dL	0.85	0.14	0.85	0.16	0.84	0.17	0.62
AST, U/L	89.1	54.1	93.6	76.5	89.2	57.9	0.83
ALT, U/L	137.5	83.5	132.2	112.9	112.0	79.6	0.008
Alk Phos, U/L	88.3	36.8	87.8	31.7	102.3	47.8	0.001
T. Bilirubin, mg/dL	0.74	0.34	0.79	0.40	0.78	0.36	0.45
Albumin, g/dL	4.04	0.37	3.94	0.34	3.84	0.39	<0.0001
INR	1.02	0.09	1.02	0.09	1.04	0.11	0.04
AFP, ng/ml	7.9	14.2	7.70	10.6	18.2	27.5	<0.0001

^*p-value for comparison of the 3 groups.